“…For example, several studies have suggested that TPP1 deficiency would completely block telomerase binding to telomeres, which in turn results in telomere attrition (Bisht et al, 2016; Nandakumar et al, 2012; Nandakumar and Cech, 2013; Xin et al, 2007). The ACD mouse, a spontaneously occurring mutant, contains a hypomorphic mutation in the mouse TPP1 gene ( Acd ), and it displays telomere dysfunction and a myriad of disease phenotypes, such as adrenal abnormality, heavy pigmentation, and reduced viability (Beamer et al, 1994; Keegan et al, 2005). Recently, mutations of TPP1 have also been found in patients with Hoyeraal-Hreidarsson syndrome, a telomere dysfunction disease that is a variant of dyskeratosis congenita (DC) (Glousker et al, 2015; Kocak et al, 2014).…”